Close Menu

Ever wonder what would happen if you skipped a step while doing your research? Prominent German anesthesiologist Joachim Boldt is facing just that problem, as he is being investigated for conducting research without first getting permission from the Institutional Review Board , says Pharmalot's Ed Silverman. Several journals are conducting further reviews as they contemplate whether to retract nearly 100 studies, Silverman says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.